CannaPharmaRx Delays Third-Quarter Report as Information Gathering Lags

PUBT · 2d ago
CannaPharmaRx Delays Third-Quarter Report as Information Gathering Lags
  • CannaPharmaRx delayed its quarterly report for September 30, 2026, because of delays obtaining and compiling required information.
  • The report is expected no later than the fifth calendar day following the prescribed due date.
  • Quarterly revenue fell to $137,705 from $656,606 a year earlier, primarily reflecting lower cannabis sales volumes.
  • Net income reached $645,416, compared with a year-earlier net loss of $1.48 million.
  • The quarterly profit primarily reflected a $1.73 million noncash gain on the change in fair value of the derivative conversion feature.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CannaPharmaRx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-008879), on November 17, 2026, and is solely responsible for the information contained therein.